New Agents for the Treatment of Acute Lymphoblastic Leukemia
New Agents for the Treatment of Acute Lymphoblastic Leukaemia (ALL), examines the strategies for the use of new agents as well as possible targets of therapy in this disease. Though associated with high cure rates, relapsed disease has a poor outcome. Moreover, therapy is unduly prolonged and toxic....
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | SpringerLink (Online service) |
Otros Autores: | Saha, Vaskar (Editor ), Kearns, Pamela (Editor ) |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2011.
|
Edición: | 1st ed. 2011. |
Temas: | |
Acceso en línea: | Texto Completo |
Ejemplares similares
-
Targeted Therapy of Acute Myeloid Leukemia
Publicado: (2015) -
Lymphoma and Leukemia of the Nervous System
Publicado: (2012) -
Vascular Disruptive Agents for the Treatment of Cancer
Publicado: (2010) -
Acute Promyelitic Leukemia Molecular Genetics, Mouse Models and Targeted Therapy /
Publicado: (2007) -
Antiangiogenic Agents in Cancer Therapy
Publicado: (2008)